Table 3.
receptor | % control response (20 μM NAB-14) | N | p-value |
---|---|---|---|
GluA1 | 101 ± 2.8 | 9 | 0.997 |
GluA2 | 101 ± 1.9 | 5 | 0.999 |
GluK2 | 101 ± 3.2 | 10 | 0.954 |
GluK2/GluK4 | 101 ± 1.9 | 5 | 0.999 |
GluK2/GluK5 | 96.5 ± 4.6 | 4 | 0.999 |
α4β2-nACh | 97.3 ± 3.9 | 3 | 0.999 |
α7-nACh | 89.6 ± 4.2 | 6 | 0.584 |
α1β2γδ-nACh | 100 ± 3.3 | 4 | 0.999 |
5-HT3A | 94.5 ± 4.5 | 7 | 0.999 |
α1β2γ2-GABAA | 107 ± 2.8 | 6 | 0.998 |
ρ-GABAA | 96.6 ± 0.8 | 5 | 0.999 |
α1-Glycine | 103 ± 2.2 | 6 | 0.999 |
P2X2 | 93.1 ± 1.6 | 5 | 0.662 |
The control current responses to agonist and the responses to agonist with 20 μM NAB-14 [% control response (mean ± s.e.m.)] for all groups were compared by one-way ANOVA [F(13,84) = 2.054, p = 0.028]. Post hoc Bonferroni tests compared the control and 20 μM NAB-14 groups for each receptor type.